Physician profile
Joann Jackson
NPI 1891218152
$2,506.69
in general payments reported to CMS, 2019-2025
19 companies · $50.72 in 2025
The $50.72 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,009 · 2022: $404 · 2023: $658 · 2024: $384 · 2025: $50.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,224.88 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Abbvie INC. | $448.78 | 2021-2024 | |
| Gilead Sciences, INC. | $299.82 | 2021-2024 | |
| Janssen Products, LP | $89.00 | 2021 | |
| Antares Pharma, INC. | $76.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.93 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $49.62 | 2023-2024 | Rexulti |
| Theratechnologies INC. | $35.90 | 2021-2024 | Egrifta Sv |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Halozyme INC | $24.46 | 2023 | |
| Janssen Biotech, INC. | $22.93 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.87 | 2021 | |
| Lundbeck LLC | $20.13 | 2021 | |
| Virtus Pharmaceuticals LLC | $18.07 | 2022 | |
| Indivior INC. | $17.79 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2021 | |
| Dynavax Technologies Corporation | $16.63 | 2022 | |
| Abbott Laboratories | $15.84 | 2022 | |
| Hologic Sales and Service, LLC | $15.75 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.